| 000 | 01620 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250512113751.0 | ||
| 264 | 0 | _c19730215 | |
| 008 | 197302s 0 0 eng d | ||
| 022 | _a0003-4819 | ||
| 024 | 7 |
_a10.7326/0003-4819-76-4-579 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aClark, D W | |
| 245 | 0 | 0 |
_aGuancydine: a new antihypertensive agent. Use with quinethazone and guanethidine or propranolol. _h[electronic resource] |
| 260 |
_bAnnals of internal medicine _cApr 1972 |
||
| 300 |
_a579-85 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article | ||
| 650 | 0 | 4 |
_aAntihypertensive Agents _xadministration & dosage |
| 650 | 0 | 4 | _aAnxiety |
| 650 | 0 | 4 |
_aAspartate Aminotransferases _xblood |
| 650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 |
_aEdema _xchemically induced |
| 650 | 0 | 4 | _aElectrocardiography |
| 650 | 0 | 4 | _aFace |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGuanethidine _xadministration & dosage |
| 650 | 0 | 4 |
_aGuanidines _xadministration & dosage |
| 650 | 0 | 4 |
_aHeart Rate _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypertension _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aParesthesia _xchemically induced |
| 650 | 0 | 4 | _aPlacebos |
| 650 | 0 | 4 |
_aPropranolol _xadministration & dosage |
| 650 | 0 | 4 |
_aSulfonamides _xadministration & dosage |
| 700 | 1 | _aGoldberg, L I | |
| 773 | 0 |
_tAnnals of internal medicine _gvol. 76 _gno. 4 _gp. 579-85 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.7326/0003-4819-76-4-579 _zAvailable from publisher's website |
| 999 |
_c4569596 _d4569596 |
||